US-based pharmaceutical company Moderna accused Pfizer and BioNTech of copying regarding the mRNA technology in the coronavirus vaccine. No clear statement has yet been received from Pfizer and BioNTech.
COVID-19, caused by the Sars-COV-2 virus, which emerged in December 2019 and paralyzed the whole world in a short time, lost its effect to a large extent with the urgent release of the developed vaccines to the market. While life has returned to its normal flow in many parts of the world, today Among the world’s two largest manufacturers of COVID-19 vaccines tensions arose.
US-based Moderna, manufacturing partners of today’s most used coronavirus vaccine suing Pfizer and BioNTech explained. Moderna, both companies developed itself before the coronavirus copying mRNA technology blamed. While it is not yet clear how much fines Moderna expects from the two companies, the lawsuit has been filed in both the US and Germany.
Two charges were filed:
Moderna alleges in the accusation that Pfizer and BioNTech copied two types of intellectual property. One is that Moderna said it began development in 2010, and in 2015 it conducted its first manned trials. was the mRNA structure. Moderna CEO, Stephane Bancel, used the following statements on the subject:
“We are filing these lawsuits to protect the innovative mRNA technology platform we pioneered, invested billions of dollars in creating and patented in the decade before the COVID-19 pandemic.”
The second intellectual property Moderna accuses of copying is found in the virus. of the ‘spike’ protein It involved encoding it in an environment other than viruses.
Pfizer could not make a statement at this time:
The BBC reached out to Pfizer, legal files have not yet reached themtherefore, announced that they could not make a comment.